The concept of glomerular self-defense

Kidney International

Volumn 55, Issue 5, 1999, Pages 1639-1671

  Kitamura, Masanori ^a   Fine, Leon G ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Ani inflammatory cytokine; Antioxidant; Cyclin kinase inhibitor; Cytokine inhibitor; Glomerulonephritis; Heat shock protein

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; CD59 ANTIGEN; CLUSTERIN; COMPLEMENT; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT FACTOR H; COMPLEMENT RECEPTOR; CYSTATIN; CYTOKINE; DECAY ACCELERATING FACTOR; DECORIN; HEAT SHOCK PROTEIN; ICOSANOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LIPOXIN; MEMBRANE COFACTOR PROTEIN; OSTEONECTIN; OXYGEN RADICAL; PHOSPHOPROTEIN PHOSPHATASE; PROSTACYCLIN DERIVATIVE; PROTEINASE INHIBITOR; SCAVENGER; SCLEROPROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG; VITRONECTIN;

EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULUS; INFLAMMATION; LEUKOCYTE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; TISSUE INJURY;

EID: 0032895532     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00425.x     Document Type: Article

References (413)

1. 1. KITAMURA M: TGF-β as an endogenous defender against macrophage-triggered stromelysin gene expression in the glomerulus. J Immunol 160:5163-5168, 1998
2. 2. SÜTÖ TS, FINE LG, SHIMIZU F, KITAMURA M: In vivo transfer of engineered macrophages into the glomerulus: Endogenous TGF-β-mediated defence against macrophage-induced glomerular cell activation. J Immunol 159:2476-2483, 1997
3. 3. SEDOR JR, NAKAZATO Y, KONIECZKOWSKI M: Interleukin-1 and the mesangial cell. Kidney Int 41:595-599, 1992
4. 4. ATKINS RC: Interleukin-1 in crescentic glomerulonephritis. Kidney Int 48:576-586, 1995
5. 5. AREND WP: Interleukin-1 receptor antagonist: A new member of the interleukin-1 family. J Clin Invest 88:1445-1451, 1991
6. 6. DINARELLO CA, THOMPSON RC: Blocking IL-1: Interleukin 1 receptor antagonist in vivo and in vitro. Immunol Today 12:404-410, 1991
7. 7. LAN HY, NIKOLIC-PATERSON DJ, ZARAMA M, VANNICE JL, ATKINS RC: Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int 43:479-485, 1993
8. 8. TANG WW, FENG L, VANNICE JL, WILSON CB: Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. J Clin Invest 93:273-279, 1994
9. 9. NIKOLIC-PATERSON DJ, LAN HY, HILL PA, VANNICE JL, ATKINS RC: Suppression of experimental glomerulonephritis by the interleukin-1 receptor antagonist: Inhibition of intercellular adhesion molecule-1 expression. J Am Soc Nephrol 4:1695-1700, 1994
10. 10. KARKAR AM, TAM FW, STEINKASSERER A, KURRLE R, LANGNER K, SCALLON BJ, MEAGER A, REES AJ: Modulation of antibody-mediated glomerular injury in vivo by IL-1ra, soluble IL-1 receptor, and soluble TNF receptor. Kidney Int 48:1738-1746, 1995
11. 11. TAM FM, KARKAR AM, SMITH J, YOSHIMURA T, STEINKASSERER A, KURRLE R, LANGNER K, REES AJ: Differential expression of macrophage inflammatory protein-2 and monocyte chemoattractant protein-1 in experimental glomerulonephritis. Kidney Int 49:715-721, 1996
12. 12. TESCH GH, LAN HY, ATKINS RC, NIKOLIC-PATERSON DJ: Role of interleukin-1 in mesangial cell proliferation and matrix deposition in experimental mesangioproliferative nephritis. Am J Pathol 151:141-150, 1997
13. 13. LAN HY, NIKOLIC-PATERSON DJ, MU W, VANNICE JL, ATKINS RC: Interleukin-1 receptor antagonist halts the progression of established crescentic glomerulonephritis in the rat. Kidney Int 47:1303-1309, 1995
14. 14. TAM FW, SMITH J, CASHMAN SJ, WANG Y, THOMPSON EM, REES AJ: Glomerular expression of interleukin-1 receptor antagonist and interleukin-1β genes in antibody-mediated glomerulonephritis. Am J Pathol 145:126-136, 1994
15. 15. SMITH MF JR, EIDLEN D, AREND WP, GUTIERREZ-HARTMANN A: LPS-induced expression of the human IL-1 receptor antagonist gene is controlled by multiple interacting promoter elements. J Immunol 153:3584-3593, 1994
16. 16. GABAY C, SMITH MF, EIDLEN D, AREND WP: Interleukin 1 receptor antagonist (IL-1ra) is an acute-phase protein. J Clin Invest 99:2930-2940, 1997
17. 17. OHMORI Y, SMITH MF JR, HAMILTON TA: IL-4-induced expression of the IL-1 receptor antagonist gene is mediated by STAT6. J Immunol 157:2058-2065, 1996
18. 18. WAHL SM, COSTA GL, CORCORAN M, WAHL LM, BERGER AE: Transforming growth factor-β mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol 150:3553-3560, 1993
19. 19. BAUD L, ARDAILLOU R: Tumor necrosis factor-α in glomerular injury. Kidney Int 45(Suppl 45):S32-S36, 1994
20. 20. MULLIGAN MS, JOHNSON KJ, TODD RF, ISSEKUTZ TB, MIYASAKA M, TAMATANI T, WAYNE-SMITH C, ANDERSON DC, WARD PA: Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest 91:577-587, 1993
21. 21. HRUBY ZW, SHIROTA K, JOTHY S, LOWRY RP: Antiserum against tumor necrosis factor-α and a protease inhibitor reduce immune glomerular injury. Kidney Int 40:43-51, 1991
22. 22. LAN HY, YANG N, METZ C, MU W, SONG Q, NIKOLIC-PATERSON DJ, BACHER M, BUCALA R, ATKINS RC: TNF-α up-regulates renal MIF expression in rat crescentic glomerulonephritis. Mol Med 3:136-144, 1997
23. 23. SUZUKI J, TOMIZAWA S, ARAI H, SEKI Y, MARUYAMA K, KUROUME T: Purification of two types of TNF inhibitors in the urine of the patient with chronic glomerulonephritis. Nephron 66:386-390, 1994
24. 24. LIEN E, LIABAKK NB, JOHNSEN AC, NONSTAD U, SUNDAN A, ESPEVIK T: Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells. Eur J Immunol 25:2714-2717,1995
25. 25. JOHNSON RJ, FLOEGE J, COUSER WG, ALPERS CE: Role of platelet-derived growth factor in glomerular disease. J Am Soc Nephrol 4:119-128, 1993
26. 26. JOHNSON RJ, RAINES EW, FLOEGE J, YOSHIMURA A, PRITZL P, ALPERS C, ROSS R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
27. 27. RAINES EW, LANE TF, IRUELA-ARISPE ML, Ross R, SAGE EH: The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptor. Proc Natl Acad Sci USA 89:1281-1285, 1992
28. 28. CHANDRASEKHAR S, HARVEY AK, JOHNSON MG, BECKER GW: Osteonectin/SPARC is a product of articular chondrocytes/cartilage and is regulated by cytokines and growth factors. Biochim Biophys Acta 1221:7-14, 1994
29. 29. FLOEGE J, JOHNSON RJ, ALPERS CE, FATEMI-NAINIE S, RICHARDSON CA, GORDON K, COUSER WG: Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain. Am J Pathol 142:637-650, 1993
30. 30. PICHLER RH, BASSUK JA, HUGO C, REED MJ, ENG E, GORDON KL, PIPPIN J, ALPERS CE, COUSER WG, SAGE EH, JOHNSON RJ: SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived growth factor-mediated mesangial cell proliferation in vitro. Am J Pathol 148:1153-1167, 1996
31. 31. BORDER WA, NOBLE NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
32. 32. ROBERTS AB, SPORN MB: The transforming growth factor-βs, in Peptide growth factors and their receptors, edited by SPORN MB, ROBERTS AB, Berlin, Springer, 1990, pp 419-472
33. 33. BORDER WA, OKUDA S, LANGUINO LR, SPORN MB, RUOSLAHTI E: Suppression of experimental glomerulonephritis by anti-serum against transforming growth factor β1. Nature 346:371-374, 1990
34. 34. AKAGI Y, ISAKA Y, ARAI M, KANEKO T, TAKENAKA M, MORIYAMA T, KANEDA Y, ANDO A, ORITA Y, KAMADA T, UEDA N, IMAI E: Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis. Kidney Int 50:148-155, 1996
35. 35. BORDER WA, NOBLE NA, YAMAMOTO T, HARPER JR, YAMAGUCHI Y, PIERSCHBACHER MD, RUOSLAHTI E: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
36. 36. ISAKA Y, BREES DK, IKEGAYA K, KANEDA Y, IMAI E, NOBLE NA, BORDER WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 2:418-423, 1996
37. 37. BORDER WA, OKUDA S, LANGUINO LR, RUOSLAHTI E: Transforming growth factor-β regulates production of proteoglycans by mesangial cells. Kidney Int 37:689-695, 1990
38. 38. OKUDA S, LANGUINO LR, RUOSLAHTI E, BORDER WA: Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
39. 39. MATRISIAN LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125, 1990
40. 40. NGUYEN HH, BARICOS WH, SHAH SV: Degradation of glomerular basement membrane by a neutral metalloproteinase(s) present in glomeruli isolated from normal rat kidney. Biochem Biophys Res Commun 141:898-903, 1986
41. 41. LOVETT DH, JOHNSON RJ, MARTI H-P, MARTIN J, DAVIES M, COUSER WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141:85-98, 1992
42. 42. EBIHARA I, NAKAMURA T, TOMINO Y, KOIDE H: Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis. Nephrol Dial Transplant 12:1001-1006, 1997
43. 43. MCMILLAN JI, RIORDAN JW, COUSER WG, POLLOCK AS, LOVETT DH: Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J Clin Invest 97:1094-1101, 1996
44. 44. SUZUKI D, MIYAZAKI M, JINDE K, KOJI T, YAGAME M, ENDOH M, NOMOTO Y, SAKAI H: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52:111-119, 1997
45. 45. MARTI HP, MCNEIL L, THOMAS G, DAVIES M, LOVETT DH: Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as PUMP-1. Biochem J 285:899-905, 1992
46. 46. BARICOS WH, SHAH SV: Proteolytic enzymes as mediators of glomerular injury. Kidney Int 40:161-173, 1991
47. 47. SHAH SV, BARICOS WH, BASCI A: Degradation of human glomerular basement membrane by stimulated neutrophils: Activation of a metalloproteinase(s) by reactive oxygen metabolites. J Clin Invest 79:25-31, 1987
48. 48. SHARMA R, SUZUKI K, NAGASE H, SAVIN VJ: Matrix metalloproteinase (stromelysin-1) increases the alubumin permeability of isolated rat glomeruli. J Lab Clin Med 128:297-303, 1996
49. 49. TURCK J, POLLOCK AS, LEE LK, MARTI HP, LOVETT DH: Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 271:15074-15083, 1996
50. 50. STEINMANN-NIGGLI K, LUKES M, MARTI HP: Rat mesangial cells and matrix metalloproteinase inhibitor: Inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation. J Am Soc Nephrol 8:395-405, 1997
51. 51. KITAMURA M, SHIRASAWA T, MARUYAMA N: Gene transfer of metalloproteinase transin induces aberrant behavior of cultured mesangial cells. Kidney Int 45:1580-1586, 1994
52. 52. WERB Z: ECM and cell surface proteolysis: Regulating cellular ecology. Cell 91:439-442, 1997
53. 53. MARTIN J, KNOWLDEN J, DAVIES M, WILLIAMS JD: Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 46:877-885, 1994
54. 54. CAROME MA, STRIKER LJ, PETEN EP, MOORE J, YANG CW, STETLER-STEVENSON WG, STRIKER GE: Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA. Am J Physiol 264:F923-F929, 1993
55. 55. KITAMURA M, MARUYAMA N, MITARAI T, NAGASAWA R, YOKOO T, SAKAI O: Heparin selectively inhibits gene expression of matrix metalloproteinase transin in cultured mesangial cells. Biochem Biophys Res Commun 203:1333-1338, 1994
56. 56. MARTI HP, LEE L, KASHGARIAN M, LOVETT DH: Transforming growth factor-β1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am J Pathol 144:82-94, 1994
57. 57. KITAMURA M, KITAMURA A, MITARAI T, MARUYAMA N, NAGASAWA R, KAWAMURA T, YOSHIDA H, TAKAHASHI T, SAKAI O: Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem Biophys Res Commun 185: 1048-1054, 1992
58. 58. SHANKLAND SJ, LY H, THAI K, SCHOLEY JW: Glomerular expression of tissue inhibitor of metalloproteinase (TIMP-1) in normal and diabetic rats. J Am Soc Nephrol 7:97-104, 1996
59. 59. REDDY VY, ZHANG QY, WEISS SJ: Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 92:3849-3853, 1995
60. 60. KIMURA Y, YOKOI-HAYASHI K: Polymorphonuclear leukocyte lysosomal proteases, cathepsins B and D affect the fibrinolytic system in human umbilical vein endothelial cells. Biochim Biophys Acta 1310:1-4, 1997
61. 61. BARICOS WH, CORTEZ SL, LE QC, ZHOU YW, DICARLO RM, O'CONNOR SE, SHAH SV: Glomerular basement membrane degradation by endogenous cysteine proteinases in isolated rat glomeruli. Kidney Int 38:395-401, 1990
62. 62. BARICOS WH, O'CONNOR SE, CORTEZ SL, WU LT, SHAH SV: The cysteine proteinase inhibitor, E-64, reduces proteinuria in an experimental model of glomerulonephritis. Biochem Biophys Res Commun 155:1318-1323, 1988
63. 63. BARICOS WH, CORTEZ SL, LE QC, WU LT, SHAW E, HANADA K, SHAH SV: Evidence suggesting a role for cathepsin L in an experimental model of glomerulonephritis. Arch Biochem Biophys 288:468-472, 1991
64. 64. BRZIN J, POPOVIC T, TURK V, BORCHART U, MACHLEIDT W: Human cystatin, a new protein inhibitor of cysteine proteinases. Biochem Biophys Res Commun 118:103-109, 1984
65. 65. ABRAHAMSON M, OLAFSSON I, PALSDOTTIR A, ULVSBACK M, LUNDWALL A, JENSSON O, GRUBB A: Structure and expression of the human cystatin C gene. Biochem J 268:287-294, 1990
66. 66. TAVERA C, LEUNG-TACK J, PREVOT D, GENSAC MC, MARTINEZ J, FULCRAND P, COLLE A: Cystatin C secretion by rat mesangial cells: Autocrine loop for in vitro growth-promoting activity. Biochem Biophys Res Commun 182:1082-1088, 1992
67. 67. QUIGG RJ: Glomerular injury induced by antibody and complement. Semin Nephrol 11:259-267, 1991
68. 68. NANGAKU M, JOHNSON RJ, COUSER WG: Glomerulonephritis and complement regulatory proteins. Exp Nephrol 5:345-354, 1997
69. 69. QUIGG RJ, NICHOLSON-WELLER A, CYBULSKY AV, BADALAMENTI J, SALANT DJ: Decay accelerating factor regulates complement activation on glomerular epithelial cells. J Immunol 142:877-882, 1989
70. 70. ABE K, MIYAZAKI M, KOJI T, FURUSU A, OZONO Y, HARADA T, SAKAI H, NAKANE PK, KOHNO S: Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney. Kidney Int 54:120-130, 1998
71. 71. COSIO FG, SEDMAK DD, MAHAN JD, NAHMAN NS JR: Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 36:100-107, 1989
72. 72. SHIBATA T, Cosio FG, BIRMINGHAM DJ: Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol 147:3901-3908, 1991
73. 73. STORCK M, ABENDROTH D, PRESTEL R, PINO-CHAVEZ G, MULLER-HOKER J, WHITE DJ, HAMMER C: Morphology of hDAF (CD55) transgenic pig kidneys following ex-vivo hemoperfusion with human blood. Transplantation 63:304-310, 1997
74. 74. QUIGG RJ, GALISHOFF ML, SNEED AE III, KIM D: Isolation and characterization of complement receptor type 1 from rat glomerular epithelial cells. Kidney Int 43:730-736, 1993
75. 75. EMANCIPATOR SN, IIDA K, NUSSENZWEIG V, GALLO GR: Monoclonal antibodies to human complement receptor (CR1) detect defects in glomerular diseases. Clin Immunol Immunopathol 27:170-175, 1983
76. 76. IIDA K, KOYAMA A, NAKAMURA H, INAGE H, NARITA M, TOJYO S, KAMISATO J, FUJITA T, TAMURA N: Abnormal expression of complement receptor (CR1) in IgA nephritis: Increase in erythrocytes and loss on glomeruli in patients with impaired renal function. Clin Immunol Immunopathol 40:393-400, 1986
77. 77. TEIXEIRA JE, COSTA RS, LACHMANN PJ, WURZNER R, BARBOSA JE: CR1 stump peptide and terminal complement complexes are found in the glomeruli of lupus nephritis patients. Clin Exp Immunol 105:497-503, 1996
78. 78. COUSER WG, JOHNSON RJ, YOUNG BA, YEH CG, TOTH CA, RUDOLPH AR: The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritis. J Am Soc Nephrol 5:1888-1894, 1995
79. 79. NAKANISHI I, MOUTABARRIK A, HARA T, HATANAKA M, HAYASHI T, SYOUJI T, OKADA N, KITAMURA E, TSUBAKIHARA Y, MATSUMOTO M, SEYA T: Identification and characterization of membrane cofactor protein (CD46) in the human kidneys. Eur J Immunol 24:1529-1535, 1994
80. 80. COSIO FG, SHIBATA T, ROVIN BH, BIRMINGHAM DJ: Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int 46:986-989, 1994
81. 81. ENDOH M, YAMASHINA M, OHI H, FUNAHASHI K, IKUNO T, YASUGI T, ATKINSON JP, OKADA H: Immunohistochemical demonstration of membrane cofactor protein (MCP) of complement in normal and diseased kidney tissues. Clin Exp Immunol 94:182-188, 1993
82. 82. QUIGG RJ, HOLERS VM, MORGAN BP, SNEED AE III: Crry and CD59 regulate complement in rat glomerular epithelial cells and are inhibited by the nephritogenic antibody of passive Heymann nephritis. J Immunol 154:3437-3443, 1995
83. 83. QUIGG RJ, MORGAN BP, HOLERS VM, ADLER S, SNEED AE III, LO CF: Complement regulation in the rat glomerulus: Crry and CD59 regulate complement in glomerular mesangial and endothelial cells. Kidney Int 48:412-421, 1995
84. 84. MOUTABARRIK A, NAKANISHI I, MATSUMOTO M, ZAID D, SEYA T: Human glomerular epithelial cells synthesize and secrete the third component of complement. Nephron 70:55-61, 1995
85. 85. SHIBATA T, KOHSAKA T: Effects of complement activation on the expression of CD59 by human mesangial cells. J Immunol 155:403-409, 1995
86. 86. NANGAKU M, MEEK RL, PIPPIN J, GORDON KL, MORGAN BP, JOHNSON RJ, COUSER WG: Transfected CD59 protects mesangial cells from injury induced by antibody and complement. Kidney Int 50:257-266, 1996
87. 87. TAMAI H, MATSUO S, FUKATSU A, NISHIKAWA K, SAKAMOTO N, YOSHIOKA K, OKADA N, OKADA H: Localization of 20-kD homologous restriction factor (HRF20) in diseased human glomeruli: An immunofluorescence study. Clin Exp Immunol 84:256-262, 1991
88. 88. LEHTO T, HONKANEN E, TEPPO AM, MERI S: Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int 47:1403-1411, 1995
89. 89. MATSUO S, NISHIKAGE H, YOSHIDA F, NOMURA A, PIDDLESDEN SJ, MORGAN BP: Role of CD59 in experimental glomerulonephritis in rats. Kidney Int 46:191-200, 1994
90. 90. NANGAKU M, ALPERS CE, PIPPIN J, SHANKLAND SJ, KUROKAWA K, ADLER S, MORGAN BP, JOHNSON RJ, COUSER WG: CD59 protects glomerular endothelial cells from immune-mediated thrombotic microangiopathy in rats. J Am Soc Nephrol 9:590-597, 1998
91. 91. NANGAKU M, QUIGG RJ, SHANKLAND SJ, OKADA N, JOHNSON RJ, COUSER WG: Overexpression of Crry protects mesangial cells from complement-mediated injury. J Am Soc Nephrol 8:223-233, 1997
92. 92. MATSUO S, ICHIDA S, TAKIZAWA H, OKADA N, BARANYI L, IGUCHI A, MORGAN BP, OKADA H: In vivo effects of monoclonal antibodies that functionally inhibit complement regulatory proteins in rats. J Exp Med 180:1619-1627, 1994
93. 93. NISHIKAGE H, BARANYI L, OKADA H, OKADA N, ISOBE K, NOMURA A, YOSHIDA F, MATSUO S: The role of a complement regulatory protein in rat mesangial glomerulonephritis. J Am Soc Nephrol 6:234-241, 1995
94. 94. LAUFER J, OREN R, FARZAM N, GOLDBERG I, PASSWELL J: Differential cytokine regulation of complement proteins in human glomerular epithelial cells. Nephron 76:276-283, 1997
95. 95. HOGASEN K, JANSEN JH, MOLLNES TE, HOVDENES J, HARBOE M: Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J Clin Invest 95:1054-1061, 1995
96. 96. FIJEN CA, KUIJPER EJ, TE BULTE M, VAN DE HEUVEL MM, HOLDRINET AC, SIM RB, DAHA MR, DANKERT J: Heterozygous and homozygous factor H deficiency states in a Dutch family. Clin Exp Immunol 105:511-516, 1996
97. 97. TlMMERMAN JJ, VAN DER WOUDE FJ, VAN GIJLSWIJK-JANSSEN DJ, VERWEIJ CL, VAN ES LA, DAHA MR: Differential expression of complement components in human fetal and adult kidneys. Kidney Int 49:730-740, 1996
98. 98. AN DEL DOBBELSTEEN ME, VERHASSELT V, KAASHOEK JG, TIMMERMAN JJ, SCHROEIJERS WE, VERWEIJ-CL, VAN DER WOUDE FJ, VAN ES LA, DAHA MR: Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL-1 and interferon-γ. Clin Exp Immunol 95:173-180, 1994
99. 99. BARIETY J, HINGLAIS N, BHAKDI S, MANDET C, ROUCHON M, KAZATCHKINE MD: Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: Relationship to neoantigens of the C5b-9 terminal complex. Clin Exp Immunol 75:76-81, 1989
100. 100. OKADA M, YOSHIOKA K, TAKEMURA T, AKANO N, AYA N, MURAKAMI K, MAKI S: Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: Association with the C5b-9 complex and vitronectin receptor. Virchows Arch A Pathol Anat Histopathol 422:367-373, 1993
101. 101. MURPHY BF, KIRSZBAUM L, WALKER ID, D'APICE AJF: SP-40,40 a newly identified normal human serum protein found in the SC5b-9 complex of complement and in the immune deposits of glomerulonephritis. J Clin Invest 81:1858-1864, 1988
102. 102. ROSENBERG ME, SILKENSEN J: Clusterin: Physiologic and pathophysiologic considerations. Int J Biochem Cell Biol 27:633-645, 1995
103. 103. FRENCH LE, TSCHOPP J, SCHIFFERLI JA: Clusterin in renal tissue: Preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli. Clin Exp Immunol 88:389-393, 1992
104. 104. MURPHY BF, DAVIES DJ, MORROW W, D'APICE AJF: Localization of terminal complement components, S-protein and SP-40,40 in renal biopsies. Pathology 21:275-278, 1989
105. 105. EDDY AA, FRITZ IB: Localization of clusterin in the epimembranous deposits of passive Heymann nephritis. Kidney Int 39:247-252, 1991
106. 106. LAPING NJ, OLSON BA, SHORT B, ALBRIGHTSON CR: Thrombin increases clusterin mRNA in glomerular epithelial and mesangial cells. J Am Soc Nephrol 8:906-914, 1997
107. 107. SAUNDERS JR, AMINIAN A, MCRAE JL, O'FARRELL KA, ADAM WR, MURPHY BF: Clusterin depletion enhances immune glomerular injury in the isolated perfused kidney. Kidney Int 45:817-827, 1994
108. 108. HALLIWELL B, GUTTERIDGE JMC: The antioxidants of human extracellular fluids. Arch Biochem Biophysiol 280:1-8, 1990
109. 109. MARKLUND SL: Extracellular Superoxide dismutase in human tissues and human cell lines. J Clin Invest 74:1398-1403, 1984
110. 110. BAKKER WW, POELSTRA K, HARDONK MJ: Relevance of adenine nucleotidases in glomerular filtration barrier. Nephron 64:338-342, 1993
111. 111. POELSTRA K, HEYNEN ER, BALLER JF, HARDONK MJ, BAKKER WW: Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides: Evidence for an anti-inflammatory role for nucleotidases. Lab Invest 66:555-563, 1992
112. 112. BAKKER WW, WILLINK EJ, DONGA J, HULSTAERT CE, HARDONK MJ: Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney. J Lab Clin Med 109:171-177, 1987
113. 113. BAKKER WW, POELSTRA K, TIMMERMAN W, HARDONK MJ, KOITER TR, SCHUILING GA: Experimental endotoxemia in pregnancy: In situ glomerular microthrombus formation associated with impaired glomerular adenosine diphosphatase activity. J Lab Clin Med 114:531-537, 1989
114. 114. POELSTRA K, HARDONK MJ, KOUDSTAAL J, BAKKER WW: Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int 37:1500-1508, 1990
115. 115. POELSTRA K, BALLER JF, HARDONK MJ, BAKKER WW: Intraglomerular thrombotic tendency and glomerular ADPase: Unilateral impairment of ADPase elicits a proaggregatory microenvironment in experimental glomerulonephritis. Lab Invest 64:520-526, 1991
116. 116. POELSTRA K, BALLER JF, HARDONK MJ, BAKKER WW: Demonstration of antithrombotic activity of glomerular adenosine diphosphatase. Blood 78:141-148, 1991
117. 117. HOOKE DH, GEE DC, ATKINS RC: Leukocytes analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987
118. 118. MAIN IW, NIKOLIC-PATERSON DJ, ATKINS RC: T cells and macrophages and their role in renal injury. Semin Nephrol 12:395-407, 1992
119. 119. KITAMURA M, SÜTÖ TS: TGF-β and glomerulonephritis: Anti-inflammatory versus prosclerotic actions. Nephrol Dial Transplant 12:669-679, 1997
120. 120. WAHL SM, MCCARTNEY-FRANCIS N, MERGENHAGEN SE: Inflammatory and immunomodulatory roles of TGF-β. Immunol Today 10:258-261, 1989
121. 121. BRANDES ME, ALLEN JB, OGAWA Y, WAHL SM: Transforming growth factor-β1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 87:1108-1113, 1991
122. 122. KURUVILLA AP, SHAH R, HOCHWALD GM, LIGGITT HD, PALLADINO MA, THORBECRE GJ: Protective effect of transforming growth factor-β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918-2921, 1991
123. 123. DANG H, GEISER AG, LETTERIO JJ, NAKABAYASHI T, KONG L, FERNANDES G, TALAL N: SLE-like autoantibodies and Sjögren syndrome-like lymphoproliferation in TGF-β knockout mice. J Immunol 155:3205-3212, 1995
124. 124. RAZ E, WATANABE A, BAIRD SM, EISENBERG RA, PARR TB, LOTZ M, KIPPS T, CARSON DA: Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci USA 90:4523-4527, 1993
125. 125. SHULL MM, ORMSBY I, KIER AB, PAWLOWSKI S, DIEBOLD RJ, YIN M, ALLEN R, SIDMAN C, PROETZEL G, CALVIN D, ANNUZIATA N, DOETSCHMAN T: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699, 1992
126. 126. KULKARNI AB, HUH CG, BECKER D, GEISER A, LYGHT M, FLANDERS KC, ROBERTS AB, SPORN MB, WARD JM, KARLSSON S: Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770-774, 1993
127. 127. CHRIST M, MCCARTNEY-FRANCIS NL, KULKARNI AB, WARD JM, MIZEL DE, MACRALL CL, GRESS RE, HINES KL, TIAN H, KARLSSON S, WAHL SM: Immune dysregulation in TGF-β1-deficient mice. J Immunol 153:1936-1946, 1994
128. 128. MACKAY K, KONDAIAH P, DANIELPOUR D, AUSTIN HA III, BROWN PD: Expression of transforming growth factor-β1 and β2 in rat glomeruli. Kidney Int 38:1095-1100, 1990
129. 129. ANDO T, OKUDA S, TAMAKI K, YOSHITOMI K, FUJISHIMA M: Localization of transforming growth factor-β and latent transforming growth factor-β binding protein in rat kidney. Kidney Int 47:733-739, 1995
130. 130. YAMAMOTO T, NOBLE NA, COHEN AH, NAST CC, HISHIDA A, GOLD LI, BORDER WA: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
131. 131. YAMAMOTO T, NOBLE NA, MILLER DE, BORDER WA: Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
132. 132. VAN DET NF, VERHAGEN NA, TAMSMA JT, BERDEN JH, BRUIJN JA, DAHA MR, VAN DER WOUDE FJ: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 46:834-840, 1997
133. 133. KANAME S, UCHIDA S, OGATA E, KUROKAWA K: Autocrine secretion of transforming growth factor-β in cultured rat mesangial cells. Kidney Int 42:1319-1327, 1992
134. 134. KITAMURA M, SÜTÖ TS, YOKOO T, SHIMIZU F, FINE LG: Transforming growth factor-β1 is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesangial cells. J Immunol 156:2964-2971, 1996
135. 135. SÜTÖ TS, FINE LG, KITAMURA M: Mesangial cell-derived transforming growth factor-β1 reduces macrophage adhesiveness with consequent deactivation. Kidney Int 50:445-452, 1996
136. 136. KAGAMI S, BORDER WA, MILLER DE, NOBLE NA: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
137. 137. WOLF G, ZIYADEH FN, STAHL RA: Atrial natriuretic peptide stimulates the expression of transforming growth factor-β in cultured murine mesangial cells: Relationship to suppression of proliferation. J Am Soc Nephrol 6:224-233, 1995
138. 138. YAMABE H, OSAWA H, INUMA H, KAIZUKA M, TAMURA N, TSUNODA S, BABA Y, SHIRATO K, ONODERA K: Thrombin stimulates production of transforming growth factor-β by cultured human mesangial cells. Nephrol Dial Transplant 12:438-442, 1997
139. 139. STUDER RK, DERUBERTIS FR, CRAVEN PA: Nitric oxide suppresses increases in mesangial cell protein kinase C, transforming growth factor β, and fibronectin synthesis induced by thromboxane. J Am Soc Nephrol 7:999-1005, 1996
140. 140. DI PAOLO S, GESUALDO L, RANIERI E, GRANDALIANO G, SCHENA FP: High glucose concentration induces the overexpression of transforming growth factor-β through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol 149:2095-2106, 1996
141. 141. DING G, VAN GOOR H, RICARDO SD, ORLOWSKI JM, DIAMOND JR: Oxidized LDL stimulates the expression of TGF-β and fibronectin in human glomerular epithelial cells. Kidney Int 51:147-154, 1997
142. 142. LOPEZ-ARMADA MJ, GOMEZ-GUERRERO C, EGIDO J: Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: Role of TGF-β. J Immunol 157:2136-2142, 1996
143. 143. RISER BL, CORTES P, HEILIG C, GRONDIN J, LADSON-WOFFORD S, PATTERSON D, NARINS RG: Cyclic stretching force selectively up-regulates transforming growth factor-β isoforms in cultured rat mesangial cells. Am J Pathol 148:1915-1923, 1996
144. 144. ESPEVIK T, FIGARI IS, SHALABY MR, LACKIDES GA, LEWIS GD, SHEPARD HM, PALLADINO MA: Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 166:571-576, 1987
145. 145. BOGDAN C, PAIK J, VODOCOTZ Y, NATHAN C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J Biol Chem 267: 23301-23308, 1992
146. 146. KITAMURA M: Identification of an inhibitor targeting macrophage production of monocyte chemoattractant protein-1 as transforming growth factor-β1. J Immunol 159:1404-1411, 1997
147. 147. SHAH SV: The role of reactive oxygen metabolites in glomerular disease. Ann Rev Physiol 57:245-262, 1995
148. 148. CATTELL V, COOK HT: Nitric oxide: Role in the physiology and pathology of the glomerulus. Exp Nephrol 1:265-280, 1993
149. 149. TSUNAWAKI S, SPORN MB, DING A, NATHAN C: Deactivation of macrophages by transforming growth factor-β. Nature 334:260-262, 1988
150. 150. DING A, NATHAN CF, GRAYCAR J, DERYNCK R, STUEHR DJ, SRIMAL S: Macrophage deactivating factor and transforming growth factor-β1, -β2, -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J Immunol 145:940-944, 1990
151. 151. JAFFER F, SAUNDERS C, SCHULTZ P, THROCKMORTON D, WEINSHELL E, ABBOUD HE: Regulation of mesangial cell growth by polypeptide mitogens: Inhibitory role of transforming growth factor-β. Am J Pathol 135:261-269, 1989
152. 152. ADLER S, CHEN X, ENG B: Control of rat glomerular epithelial cell growth in vitro. Kidney Int 37:1048-1054, 1990
153. 153. CHOI ME, BALLERMANN BJ: Inhibition of capillary morphogenesis and associated apoptosis by dominant negative mutant transforming growth factor-β receptors. J Biol Chem 270:21144-21150, 1995
154. 154. KITAMURA M, BURTON S, ENGLISH J, KAWACHI H, FINE LG: Transfer of a mutated gene encoding active transforming growth factor-β1 suppresses mitogenesis and IL-1 response in the glomerulus. Kidney Int 48:1747-1757, 1995
155. 155. KITAMURA M, TAYLOR S, UNWIN R, BURTON S, SHIMIZU F, FINE LG: Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J Clin Invest 94:497-505, 1994
156. 156. REDINI F, MAUVIEL A, PRONOST S, LOYAU G, PUJOL J-P: Transforming growth factor-β exerts opposite effects from interleukin-1β on cultured rabbit articular chondrocytes through reduction of interleukin-1 receptor expression. Arthritis Rheum 36:44-50, 1993
157. 157. VAN BEUNINGEN HM, VAN DER KRAAN PM, ARNTZ OJ, VAN DER BERG WB: Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor-β: Studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 52:185-191, 1993
158. 158. DUBOIS CM, RUSCETTI FW, PALASZYNSKI EW, FALK LA, OPPENHEIM JJ, KELLER JR: Transforming growth factor β is a potent inhibitor of IL-1 receptor expression: Proposed mechanism of inhibition on IL-1 action. J Exp Med 172:737-744, 1990
159. 159. PFEILSCHIFTER J, VOSBECK K: Transforming growth factor β2 inhibits interleukin 1β-and tumour necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun 175:372-379, 1991
160. 2 mRNA and activity levels in interleukin 1β and forskolin-stimulated mesangial cells. Biochem J 315:435-441, 1996
161. 161. KITAMURA M, SÜTÖ TS: Transfer of genetically engineered macrophages into the glomerulus. Kidney Int 51:1274-1279, 1997
162. 162. LAKKIS FG, BADDOURA FK, CRUET EN, PAREKH KR, FUKUNAGA M, MUNGER KA: Anti-inflammatory lymphokine mRNA expression in antibody-induced glomerulonephritis. Kidney Int 49:117-126, 1996
163. 163. OKADA H, KONISHI K, NAKAZATO Y, KANNO Y, SUZUKI H, SAKAGUCHI H, SARUTA T: Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am J Kidney Dis 23:242-246, 1994
164. 164. FURUSU A, MIYAZAKI M, KOJI T, ABE K, OZONO Y, HARADA T, NAKANE PK, HARA K, KOHNO S: Involvement of IL-4 in human glomerulonephritis: An in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol 8:730-741, 1997
165. 165. KLUTH DC, REES AJ: Inhibiting inflammatory cytokines. Semin Nephrol 16:576-582, 1996
166. 166. TIPPING PG, KITCHING AR, HUANG XR, MUTCH DA, HOLDSWORTH SR: Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27:530-537, 1997
167. 167. KITCHING AR, TIPPING PG, MUTCH DA, HUANG XR, HOLDSWORTH SR: Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int 53:112-118, 1998
168. 168. ERB KJ, RUGER B, VON BREVERN M, RYFFEL B, SCHIMPL A, RIVETT K: Constitutive expression of interleukin-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 185:329-339, 1997
169. 169. SCHORLEMMER HU, DICKNEITE G, KANZY EJ, ENSSLE KH: Modulation of the immunoglobulin dysregulation in GvH-and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Inflamm Res 44(Suppl 2):S194-S196, 1995
170. 170. NAKAZATO Y, OKADA H, SATO A, IWAITA Y, HAYASHIDA T, HAYASHI M, SUZUKI H, SARUTA T: Interleukin 4 downregulates cell growth and prostaglandin release of human mesangial cells. Biochem Biophys Res Commun 197:486-493, 1993
171. 171. SAVAGE CO, BROOKS CJ, ADU D, RICHARDS G, HOWIE AJ: Cell adhesion molecule expression within human glomerular and kidney organ culture. J Pathol 181:111-115, 1997
172. 172. MOUTABARRIK A, NAKANISHI I, ISHIBASHI M: Interleukin-6 and interleukin-6 receptor are expressed by cultured glomerular epithelial cells. Scand J Immunol 40:181-186, 1994
173. 173. HORII Y, MURAGUCHI A, IWANO M, MATSUDA T, HIRAYAMA T, YAMADA H, FUJII Y, DOHI K, ISHIKAWA H, OHMOTO Y, YOSHIZAKI K, HIRANO T, KISHIMOTO T: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 143:3949-3955, 1989
174. 174. ZOJA C, WANG JM, BETTONI S, SIRONI M, RENZI D, CHIAFFARINO F, ABBOUD HE, VAN-DAMME J, MANTOVANI A, REMUZZI G: Interleukin-1β and tumor necrosis factor-α induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol 138:991-1003, 1991
175. 175. ZIESCHE R, ROTH M, PAPAKONSTANTINOU E, NAUCK M, HÖRL WH, KASHGARIAN M, BLOCK LH: A granulocyte inhibitory protein overexpressed in chronic renal disease regulates expression of interleukin 6 and interleukin 8. Proc Natl Acad Sci USA 91:301-305, 1994
176. 176. MORIYAMA T, FUJIBAYASHI M, FUJIWARA Y, KANEKO T, XIA C, IMAI E, KAMADA T, ANDO A, UEDA N: Angiotensin II stimulates interleukin-6 release from cultured mouse mesangial cells. J Am Soc Nephrol 6:95-101, 1995
177. 177. VAN DEN DOBBELSTEEN ME, VAN DER WOUDE FJ, SCHROEIJERS WE, VAN ES LA, DAHA MR: Soluble aggregates of IgG and immune complexes enhance IL-6 production by renal mesangial cells. Kidney Int 43:544-553, 1993
178. 178. FUKATSU A, MATSUO S, TAMAI H, SAKAMOTO N, MATSUDA T, HIRANO T: Distribution of interleukin-6 in normal and diseased human kidney. Lab Invest 65:61-66, 1991
179. 179. CHEN WP, LIN CY: Augmented expression of interleukin-6 and interleukin-1 genes in the mesangium of IgM mesangial nephropathy. Nephron 68:10-19, 1994
180. 180. SUEMATSU S, MATSUDA T, AOZASA K, AKIRA S, NAKANO N, OHNO S, MIYAZAKI J, YAMAMURA K, HIRANO T, KISHIMOTO T: IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86:7547-7551, 1989
181. 181. HARTNER A, GOPPELT-STRUEBE M, HOCKE GM, STERZEL RB: Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int 51:1754-1760, 1997
182. 182. RYFFEL B, CAR BD, GUNN H, ROMAN D, HIESTAND P, MIHATSCH MJ: Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW) F1 mice. Am J Pathol 144:927-937, 1994
183. 183. KIBERD BA: Interleukin-6 receptor blockage ameliorates murine lupus nephritis. J Am Soc Nephrol 4:58-61, 1993
184. 184. FLOEGE J, ENG E, YOUNG BA, ALPERS CE, BARRETT TB, BOWEN-POPE DF, JOHNSON RJ: Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993
185. 185. EITNER F, WESTERHUIS R, BURG M, WEINHOLD B, GRONE HJ, OSTENDORF T, RUTHER U, KOCH KM, REES AJ, FLOEGE J: Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo. Kidney Int 51:69-78, 1997
186. 186. IKEDA M, IKEDA U, OHARA T, KUSANO E, KANO S: Recombinant interleukin-6 inhibits the growth of rat mesangial cells in culture. Am J Pathol 141:327-334, 1992
187. 187. MATSELL DG, GABER LW, MALIK KU: Cytokine stimulation of prostaglandin production inhibits the proliferation of serum-stimulated mesangial cells. Kidney Int 45:159-165, 1994
188. 188. KARKAR AM, TAM FW, PROUDFOOT AE, MEAGER A, REES AJ: Modulation of antibody-mediated glomerular injury in vivo by interleukin-6. Kidney Int 44:967-973, 1993
189. 189. XING Z, GAULDIE J, Cox G, BAUMANN H, JORDANA M, LEI X-F, ACHONG MK: IL-6 is an anti-inflammatory cytokine required for controlling local and systemic acute inflammatory responses. J Clin Invest 101:311-320, 1998
190. 190. FIORENTINO DF, ZLOTNIK A, MOSMANN TR, HOWARD MH, O'GARRA A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
191. 191. DE WAAL-MALEFYT R, ABRAMS J, BENNETT B, FIGDOR C, DE VRIES J: IL-10 inhibits cytokine synthesis by human monocytes: An auto-regulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220, 1991
192. 192. BOGDAN C, VODOVOTZ Y, NATHAN C: Macrophage deactivation by interleukin 10. J Exp Med 174:1548-1555, 1991
193. 193. HOWARD M, O'GARRA A: Biological properties of interleukin 10. Immunol Today 13:198-200, 1992
194. 194. JOYCE DA, GIBBONS DP, GREEN P, STEER JH, FELDMANN M, BRENNAN FM: Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on the release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24:2699-2705, 1994
195. 195. KITCHING AR, TIPPING PG, HUANG XR, MUTCH DA, HOLDSWORTH SR: Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 52:52-59, 1997
196. 196. CHADBAN SJ, TESCH GH, FOTI R, ATKINS RC, NIKOLIC-PATERSON DJ: Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Lab Invest 76:619-627, 1997
197. 197. FOUQUERAY B, BOUTARD V, PHILIPPE C, KORNREICH A, MARCHANT A, PEREZ J, GOLDMAN M, BAUD L: Mesangial cell-derived interleukin-10 modulates mesangial cell response to lipopolysaccharide. Am J Pathol 147:176-182, 1995
198. 198. ZURAWSKI G, DE VRIES JE: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 15:19-26, 1994
199. 199. LAKKIS FG, CRUET EN: Cloning of rat interleukin-13 (IL-13) cDNA and analysis of IL-13 gene expression in experimental glomerulonephritis. Biochem Biophys Res Commun 197:612-618, 1993
200. 200. TANG WW, QI M, VAN GY, WARINER GP, SAMAL B: Leukemia inhibitory factor ameliorates experimental anti-GBM Ab glomerulonephritis. Kidney Int 50:1922-1927, 1996
201. 201. HARTNER A, STERZEL RB, REINDL N, HOCKE GM, FEY GH, GOPPELT-STRUEBE M: Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells. Kidney Int 45:1562-1571, 1994
202. 202. LIANOS EA: Eicosanoids in immune-mediated renal injury. Semin Nephrol 12:441-453, 1992
203. 203. O'MEARA YM, BRADY HR: Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Kidney Int 51(Suppl 58):S56-S61, 1997
204. 204. DIAZ-PEREZ JL, GOLDYNE ME, WINKELMANN RK: Prostaglandins and chemotaxis: Enhancement of polymorphonuclear leukocyte chemotaxis by prostaglandin F2α. J Invest Dermatol 66:149-152, 1976
205. 205. GOODWIN JS, CEUPPENS J: Regulation of the immune response by prostaglandins. J Clin Immunol 3:295-315, 1983
206. 206. WEBB DR, OSHEROFF PL: Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci USA 73:1300-1304, 1976
207. 207. BRUNDA MJ, HERBERMAN RB, HOLDEN HT: Inhibition of murine natural killer cell activity by prostaglandins. J Immunol 124:2682-2687, 1980
208. 208. FANTONE JC, MARASCO WA, ELGAS LJ, WARD PA: Anti-inflammatory effects of prostaglandin E1: In vivo modulation of the formyl peptide chemotactic receptor on the rat neutrophil. J Immunol 130:1495-1497, 1983
209. 2 inhibits TNF-α release via a mechanism involving IL-10. J Immunol 154:3383-3390, 1995
210. 2 and selective EP agonists on chemotaxis of human neutrophils. Br J Pharmacol 116:2903-2908, 1995
211. 211. KUNKEL SL, CHENSUE SW, PHAN SH: Prostaglandins as endogenous mediators of interleukin 1 production. J Immunol 136:186-192, 1986
212. 212. MONCADA S, VANE JR: The role of prostacycline in vascular tissue. Fed Proc 38:66-71, 1979
213. 213. MENE P, DUNN MJ: Prostaglandins and rat glomerular mesangial cell proliferation. Kidney Int 37:1256-1262, 1990
214. 2 on mRNA expression and secretion of collagens I III, and IV and fibronectin in cultured rat mesangial cells. J Am Soc Nephrol 4:1778-1785, 1994
215. 215. NITTA K, SIMONSON MS, DUNN MJ: The regulation and role of prostaglandin biosynthesis in cultured bovine glomerular endothelial cells. J Am Soc Nephrol 2:156-163, 1991
216. 216. PETRULIS AS, AIKAWA M, DUNN MJ: Prostaglandin and thromboxane synthesis by rat glomerular epithelial cells. Kidney Int 20:469-474, 1981
217. 217. SCHARSCHMIDT LA, DUNN MJ: Prostaglandin synthesis by rat glomerular mesangial cells in culture: Effects of angiotensin II and arginine vasopressin. J Clin Invest 71:1756-1764, 1983
218. 218. LIANOS EA, BRESNAHAN BA, PAN C: Mesangial cell immune injury: Synthesis, origin, and role of eicosanoids. J Clin Invest 88:623-631, 1991
219. 219. FLOEGE J, TOPLEY N, WESSEL K, KAEVER V, RADEKE H, HOPPE J, KISHIMOTO T, RESCH K: Monokines and platelet-derived growth factor modulate prostanoid production in growth arrested, human mesangial cells. Kidney Int 37:859-869, 1990
220. 220. SCHARSCHMIDT LA, DUNN MJ: Prostaglandin synthesis by rat glomerular mesangial cells in culture: Effects of angiotensin II and arginine vasopressin. J Clin Invest 71:1756-1764, 1983
221. 221. HUGHES AK, PADILLA E, KUTCHERA WA, MICHAEL JR, KOHAN DE: Endothelin-1 induction of cyclooxygenase-2 expression in rat mesangial cells. Kidney Int 47:53-61, 1995
222. 222. ALBRIGHTSON CR, NAMBI P, ZABKO-POTAPOVICH B, DYTKO G, GROOM T: Effect of thrombin on proliferation, contraction and prostaglandin production of rat glomerular mesangial cells in culture. J Pharmacol Exp Ther 263:404-412, 1992
223. 223. ADLER S, STAHL RA, BAKER PJ, CHEN YP, PRITZL PM, COUSER WG: Biphasic effect of oxygen radicals on prostaglandin production by rat mesangial cells. Am J Physiol 252:F743-F749, 1987
224. 224. TETSUKA T, DAPHNA-IKEN D, MILLER BW, GUAN Z, BAIER LD, MORRISON AR: Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells. J Clin Invest 97:2051-2056, 1996
225. 225. NEUWIRTH R, SINGHAL P, DIAMOND B, HAYS RM, LOBMEYER L, CLAY K, SCHLÖNDORFF D: Evidence for immunoglobulin Fc receptor-mediated prostaglandin and platelet-activating factor formation by cultured rat mesangial cells. J Clin Invest 82:936-944, 1988
226. 226. LIEBERTHAL W, LEVINE L: Stimulation of prostaglandin production in rat glomerular epithelial cells by antidiuretic hormone. Kidney Int 25:766-770, 1984
227. 227. LIANOS EA, ANDRES GA, DUNN MJ: Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis: Effects on renal hemodynamics. J Clin Invest 72:1439-1448, 1983
228. 228. STAHL RA, ADLER S, BAKER PJ, CHEN YP, PRITZL PM, COUSER WG: Enhanced glomerular prostaglandin formation in experimental membranous nephropathy. Kidney Int 31:1126-1131,1987
229. 2: Dose-response of immune complex deposition, antibody synthesis, and glomerular damage. Clin Immunol Immunopathol 26:18-23, 1983
230. 2 treatment of murine immune complex glomerulonephritis. J Lab Clin Med 106:517-523, 1985
231. 231. POELSTRA K, BROUWER E, BALLER JF, HARDONK MJ, BAKKER WW: Attenuation of anti-Thy1 glomerulonephritis in the rat by anti-inflammatory platelet-inhibiting agents. Am J Pathol 142:441-450, 1993
232. 4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. Clin Sci 77:195-203, 1989
233. 4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 156:2264-2272, 1996
234. 4 during adhesion of platelets and neutrophils in experimental immune complex glomerulonephritis. Kidney Int 47:1295-1302, 1995
235. 235. MAYADAS TN, MENDRICK DL, BRADY HR, TANG T, PAPAYIANNI A, ASSMANN KJ, WAGNER DD, HYNES RO, COTRAN RS: Acute passive anti-glomerular basement membrane nephritis in P-selectin-deficient mice. Kidney Int 49:1342-1349, 1996
236. 4 to lipoxins by rat kidney mesangial cell. Biochem Biophys Res Commun 162:626-633, 1989
237. 4 production in rat mesangial cells. Adv Prostaglandin Thromb Leuk Res 21B:701-706, 1991
238. 238. KATOH T, LAKKIS FG, MAKITA N, BADR KF: Co-regulated expression of glomerular 12/15-lipoxygenase and interleukin-4 mRNAs in rat nephrotoxic nephritis. Kidney Int 46:341-349, 1994
239. 239. BRADY HR, PERSSON U, BALLERMANN BJ, BRENNER BM, SERHAN CN: Leukotrienes stimulate neutrophil adhesion to mesangial cells: Modulation with lipoxins. Am J Physiol 259:F809-F815, 1990
240. 240. KELEFIOTISD, BRESNAHAN BA, STRATIDAKIS I, LIANOS EA: Eicosanoid-induced growth and signaling events in rat glomerular mesangial cells. Prostaglandins 49:269-283, 1995
241. 4 in rat glomerular mesangial cells: Evidence for competition at a common receptor. Proc Natl Acad Sci USA 86:3438-3442, 1989
242. 242. VOLL RE, HERRMANN M, ROTH EA, STACH C, KALDEN JR, GIRKONTAITE I: Immunosuppresive effects of apoptotic cells. Nature 390:350-351, 1997
243. 2, and PAF. J Clin Invest 101:890-898, 1998
244. 244. HARRISON DJ: Cell death in the diseased glomerulus. Histopathology 12:679-683, 1988
245. 245. BAKER AJ, MOONEY A, HUGHES J, LOMBARDI D, JOHNSON RJ, SAVILL J: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
246. 246. TAKEMURA T, MURAKAMI K, MIYAZATO H, YAGI K, YOSHIOKA K: Expression of Fas and Bcl-2 in human glomerulonephritis. Kidney Int 48:1886-1892, 1995
247. 247. SHIMIZU A, MASUDA Y, KITAMURA H, ISHIZAKI M, SUGISAKI Y, YAMANAKA N: Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 74:941-951, 1996
248. 248. SUGIYAMA H, KASHIHARA N, MAKINO H, YAMASAKI Y, OTA Z: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
249. 249. KITAMURA M, MITARAI T, MARUYAMA N, NAGASAWA R, YOSHIDA H, SAKAI O: Mesangial cell behavior in a three-dimensional extracellular matrix. Kidney Int 40:653-661, 1991
250. 250. YAOITA E: Behavior of rat mesangial cells cultured within extracellular matrix. Lab Invest 61:410-418, 1989
251. 251. KITAMURA M, ISHIKAWA Y: Three-dimensional matrix primes mesangial cells to down-regulation of α-smooth muscle actin via deactivation of CArG box elements. Kidney Int 53:690-697, 1998
252. 252. KITAMURA M, MITARAI T, NAGASAWA R, MARUYAMA N: Differentiated phenotype of glomerular mesangial cells in nodular culture. Am J Physiol 270:F614-F622, 1996
253. 253. TOYABE S, IWANAGA T: An ultrastructural study of proliferative nephritis induced experimentally by a monoclonal antibody against mesangial cells. Virchows Arch B Cell Pathol 61:397-407, 1992
254. 254. STEINMANN-NIGGLI K, ZISWILER R, KUNG M, MARTI H-P: Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis. J Am Soc Nephrol 9:397-407, 1998
255. 255. MARX M, DANIEL TO, KASHGARIAN M, MADRI JA: Spatial organization of the extracellular matrix modulates the expression of PDGF-receptor subunits in mesangial cells. Kidney Int 43:1027-1041, 1993
256. 256. JOHNSON RJ: Platelets in inflammatory glomerular injury. Semin Nephrol 11:276-284, 1991
257. 257. DEBAULT LE, ESMON NL, OLSON JR, ESMON CT: Distribution of the thrombomodulin antigen in the rabbit vasculature. Lab Invest 54:172-178, 1986
258. 258. MIZUTANI M, YUZAWA Y, MARUYAMA I, SAKAMOTO N, MATSUO S: Glomerular localization of thrombomodulin in human glomerulonephritis. Lab Invest 69:193-202, 1993
259. 259. HE CJ, KANFER A: Quantification and modulation of thrombomodulin activity in isolated rat and human glomeruli. Kidney Int 41:1170-1174, 1992
260. 260. PRUNA A, PEYRI N, BERARD M, BOFFA MC: Thrombomodulin is synthesized by human mesangial cells. Kidney Int 51:687-693, 1997
261. 261. GONDA Y, HlRATA S, SAITOH K, AOKI Y, MOHRI M, GOMI K, SUGIHARA T, KIYOTA T, YAMAMOTO S, ISHIDA T: Antithrombotic effect of recombinant human soluble thrombomodulin on endotoxin-induced disseminated intravascular coagulation in rats. Thromb Res 71:325-335, 1993
262. 262. BREGENGARD C, NORDFANG O, WILDGOOSE P, SVENDSEN O, HEDNER U, DINESS V: The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits. Blood Coagul Fibrinolysis 4:699-706, 1993
263. 263. ERLICH JH, APOSTOLOPOULOS J, WUN TC, KRETZMER KK, HOLDSWORTH SR, TIPPING PG: Renal expression of tissue factor pathway inhibitor and evidence for a role in crescentic glomerulonephritis in rabbits. J Clin Invest 98:325-335, 1996
264. 264. YAMABE H, OSAWA H, INUMA H, KAIZUKA M, TAMURA N, TSUNODA S, FUJITA Y, SHIRATO K, ONODERA K: Tissue factor pathway inhibitor production by human mesangial cells in culture. Thromb Haemost 76:215-219, 1996
265. 265. MALLIAROS J, HOLDSWORTH SR, WOJTA J, ERLICH J, TIPPING PG: Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits. Kidney Int 44:557-564, 1993
266. 266. ZOJA C, CORNA D, MACCONI D, ZILIO P, BERTANI T, REMUZZI G: Tissue plasminogen activator therapy of rabbit nephrotoxic nephritis. Lab Invest 62:34-40, 1990
267. 267. ANGLES-CANO E, RONDEAU E, DELARUE F, HAGEGE J, SULTAN Y, SRAER JD: Identification and cellular localization of plasminogen activators from human glomeruli. Thromb Haemost 54:688-692, 1985
268. 268. AYA N, YOSHIOKA K, MURAKAMI K, HINO S, OKADA K, MATSUO O, MAKI S: Tissue-type plasminogen activator and its inhibitor in human glomerulonephritis. J Pathol 166:289-295, 1992
269. 269. YAMAMOTO K, LOSKUTOFF DJ: The kidneys of mice with autoimmune disease acquire a hypofibrinolytic/procoagulant state that correlates with the development of glomerulonephritis and tissue microthrombosis. Am J Pathol 151:725-734, 1997
270. 270. LACAVE R, RONDEAU E, OCHI S, DELARUE F, SCHLEUNING WD, SRAER JD: Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 35:806-811, 1989
271. 271. IWAMOTO T, NAKASHIMA Y, SUEISHI K: Secretion of plasminogen activator and its inhibitor by glomerular epithelial cells. Kidney Int 37:1466-1476, 1990
272. 272. WILSON HM, HAITES NE, REID FJ, BOOTH NA: Interleukin-1β up-regulates the plasminogen activator/plasmin system in human mesangial cells. Kidney Int 49:1097-1104, 1996
273. 273. KITCHING AR, HOLDSWORTH SR, PLOPLIS VA, PLOW EF, COLLEN D, CARMELIET P, TIPPING PG: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 185:963-968, 1997
274. 274. STRIKER LJ, PETEN EP, ELLIOT SJ, DOI T, STRIKER GE: Mesangial cell turnover: Effect of heparin and peptide growth factors. Lab Invest 64:446-456, 1991
275. 275. WARDLE EN: Heparins for proliferative nephritides? Short review on an advancing topic. Nephron 73:515-519, 1996
276. 276. MARCUM JA, ATHA DH, FRITZE LM, NAWROTH P, STERN D, ROSENBERG RD: Cloned bovine aortic endothelial cells synthesize anticoagulantly active heparan sulfate proteoglycan. J Biol Chem 261:7507-7517, 1986
277. 277. FERRER-LOPEZ P, RENESTO P, PREVOST MC, GOUNON P, CHIGNARD M: Heparin inhibits neutrophil-induced platelet activation via cathepsin G. J Lab Clin Med 119:231-239, 1992
278. 278. YOKOKAWA K, TAHARA H, KOHNO M, MANDAL AK, YANAGISAWA M, TAKEDA T: Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest 92:2080-2085, 1993
279. 279. VAIREL EG, BOUTY-BOYE H, TOULEMONDE F, DOUTREMEPUICH C, MARSH NA, GAFFNEY PJ: Heparin and a low molecular weight fraction enhances thrombolysis and by this pathway exercises a protective effect against thrombosis. Thromb Res 30:219-224, 1983
280. 280. WEILER JM, EDENS RE, LINHARDT RJ, KAPELANSKI DP: Heparin and modified heparin inhibit complement activation in vivo. J Immunol 148:3210-3215, 1992
281. 281. EKRE HP, NAPARSTEK Y, LIDER O, HYDEN P, HAGERMARK O, NILSSON T, VLODAVSKY I, COHEN I: Anti-inflammatory effects of heparin and its derivatives: Inhibition of complement and of lymphocyte migration. Adv Exp Med Biol 313:329-340, 1992
282. 282. CAUGHMAN GB, BOACKLE RJ, VESELY J: A postulated mechanism for heparin's potentiation of C1 inhibitor function. Mol Immunol 19:287-295, 1982
283. 283. KAZATCHKINE MD, FEARON DT, SILBERT JE, AUSTEN KF: Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b. J Exp Med 150:1202-1215, 1979
284. 284. KENAGY RD, NIKKARI ST, WELGUS HG, CLOWES AW: Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest 93:1987-1993, 1994
285. 285. WALSH RL, DILLON TJ, SCICCHITANO R, MCLENNAN G: Heparin and heparan sulphate are inhibitors of human leucocyte elastase. Clin Sci (Colch) 81:341-346, 1991
286. 286. LEY K, CERRITO M, ARFORS KE: Sulfated polysaccharides inhibit leukocyte rolling in rabbit mesentery venules. Am J Physiol 260:H1667-H1673, 1991
287. 287. BAZZONI G, BELTRAN-NUNEZ A, MASCELLANI G, BIANCHINI P, DEJANA E, DEL-MASCHIO A: Effect of heparin, dermatan sulfate, and related oligo-derivatives on human polymorphonuclear leukocyte functions. J Lab Clin Med 121:268-275, 1993
288. 288. NELSON RM, CECCONI O, ROBERTS WG, ARUFFO A, LINHARDT RJ, BEVILACQUA MP: Heparin oligosaccharides bind L-and P-selectin and inhibit acute inflammation. Blood 82:3253-3258, 1993
289. 289. GARRED P, MOLLNES TE: Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules. Artif Organs 21:293-299, 1997
290. 290. MATZNER Y, MARX G, DREXLER R, ELDOR A: The inhibitory effect of heparin and related glycosaminoglycans on neutrophil chemotaxis. Thromb Haemost 52:134-137, 1984
291. 291. LAGHI-PASINI F, PASQUI AL, CECCATELLI L, CAPECCHI PL, ORRICO A, DI-PERRI T: Heparin inhibition of polymorphonuclear leukocyte activation in vitro: A possible pharmacological approach to granulocyte-mediated vascular damage. Thromb Res 35:527-537, 1984
292. 292. MAVIER P, PREAUX AM, ROSENBAUM J, ZAFRANI ES, DHUMEAUX D: Toxicity of polymorphonuclear neutrophils against hepatocytes: Protective effect of heparin. Biochem Pharmacol 38:1865-1867, 1989
293. 293. MANASTER J, CHEZAR J, SHURTZ-SWIRSKI R, SHAPIRO G, TENDLER Y, KRISTAL B, SHASHA SM, SELA S: Heparin induces apoptosis in human peripheral blood neutrophils. Br J Haematol 94:48-52, 1996
294. 294. LEUNG L, SAIGO K, GRANT D: Heparin binds to human monocytes and modulates their procoagulant activities and secretory phenotypes: Effects of histidine-rich glycoprotein. Blood 73:177-184, 1989
295. 295. CASTELLOT JJ JR, HOOVER RL, HARPER PA, KARNOVSKY MJ: Heparin and glomerular epithelial cell-secreted heparin-like species inhibit mesangial-cell proliferation. Am J Pathol 120:427-435, 1985
296. 296. CASTELLOT JJ JR, HOOVER RL, KARNOVSKY MJ: Glomerular endothelial cells secrete a heparinlike inhibitor and a peptide stimulator of mesangial cell proliferation. Am J Pathol 125:493-500, 1986
297. 297. GROGGEL GC, MARINIDES GN, HOVINGH P, HAMMOND E, LINKER A: Inhibition of rat mesangial cell growth by heparan sulfate. Am J Physiol 258:F259-F265, 1990
298. 298. PERSON JM, LOVETT DH, RAUGI GJ: Modulation of mesangial cell migration by extracellular matrix components: Inhibition by heparinlike glycosaminoglycans. Am J Pathol 133:609-614, 1988
299. 299. MIRALEM T, WANG A, WHITESIDE CI, TEMPLETON DM: Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells. J Biol Chem 271:17100-17106, 1996
300. 300. HOFER G, GRIMMER C, SUKHATME VP, STERZEL RB, RUPPRECHT HD: Transcription factor Egr-1 regulates glomerular mesangial cell proliferation. J Biol Chem 271:28306-29310, 1996
301. 301. CAENAZZO C, GARBISA S, CEOL M, BAGGIO B, BORSATTI A, MARCHI E, GAMBARO G: Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: Molecular clues for its activity in nephropathy. Nephrol Dial Transplant 10:175-184, 1995
302. 302. ISHIKAWA Y, KITAMURA M: Spontaneous apoptosis of podocytes in isolated glomeruli. Kidney Int 54:2008-2013, 1998
303. 303. ADLER S: Inhibition of rat glomerular visceral epithelial cell growth by heparin. Am J Physiol 255:F781-F786, 1988
304. 304. ADLER S: Heparin alters epidermal growth factor metabolism in cultured rat glomerular epithelial cells. Am J Pathol 139:169-175, 1991
305. 305. KARLSSON K, MARKLUND SL: Heparin-induced release of extracellular Superoxide dismutase to human blood plasma. Biochem J 242:55-59, 1987
306. 306. HIEBERT LM, LIU JM: Heparin protects cultured arterial endothelial cells from damage by toxic oxygen metabolites. Atherosclerosis 83:47-51, 1990
307. 307. KANWAR YS, ROSENZWEIG LJ, JAKUBOWSKI ML: Distribution of de novo synthesized sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix. Lab Invest 49:216-225, 1983
308. 308. GROFFEN AJ, HOP FW, TRYGGVASON K, DIJKMAN H, ASSMANN KJ, VEERKAMP JH, MONNENS LA, VAN DEN HEUVEL LP: Evidence for the existence of multiple heparan sulfate proteoglycans in the human glomerular basement membrane and mesangial matrix. Eur J Biochem 247:175-182, 1997
309. 309. RUPPRECHT HD, SCHOCKLMANN HO, STERZEL RB: Cell-matrix interaction in the glomerular mesangium. Kidney Int 49:1575-1582, 1996
310. 310. THOMAS GJ, MASON RM, DAVIES M: Characterization of proteoglycans synthesized by human adult glomerular mesangial cells in culture. Biochem J 277:81-88, 1991
311. 311. VAN DET NF, VAN DEN BORN J, TAMSMA JT, VERHAGEN NA, VAN DEN HEUVEL LP, BERDEN JH, BRUIJN JA, DAHA MR, VAN DER WOUDE FJ: Proteoglycan production by human glomerular visceral epithelial cells and mesangial cells in vitro. Biochem J 307:759-768, 1995
312. 312. KOLM V, SAUER U, OLGEMOOLLER B, SCHLEICHER ED: High glucose-induced TGF-β1 regulates mesangial production of heparan sulfate proteoglycan. Am J Physiol 270:F812-F821, 1996
313. 313. VAN DET NF, TAMSMA JT, VAN DEN BORN J, VERHAGEN NA, VAN DEN HEUVEL LP, LOWIK CW, BERDEN JH, BRUIJN JA, DAHA MR, VAN DER WOUDE FJ: Differential effects of angiotensin II and transforming growth factor-β on the production of heparan sulfate proteoglycan by mesangial cells in vitro. J Am Soc Nephrol 7:1015-1023, 1996
314. 314. RAIJ L, BAYLIS C: Glomerular actions of nitric oxide. Kidney Int 48:20-32, 1995
315. 315. PRYOR WA, SQUADRITO GL: The chemistry of peroxynitrite: A product from the reaction of nitric oxide with Superoxide. Am J Physiol 268:L699-L722, 1995
316. 316. SHULTZ PJ, TAYEH MA, MARLETTA MA, RAIJ L: Synthesis and action of nitric oxide in rat glomerular mesangial cells. Am J Physiol 261:F600-F606, 1991
317. 317. PFEILSCHIFTER J, ROB P, MULSCH A, FANDREY J, VOSBECK K, BUSSE R: Interleukin 1-β and tumour necrosis factor-α induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem 203:251-255, 1992
318. 318. SANDAU K, PFEILSCHIFTER J, BRUNE B: The balance between nitric oxide and Superoxide determines apoptotic and necrotic death of rat mesangial cells. J Immunol 158:4938-4946, 1997
319. 319. KUBES P, SUZUKI M, GRANGER DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991
320. 320. CLANCY RM, LESZCZYNSKA-PIZIAK J, ABRAMSON SB: Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 90:1116-1121, 1992
321. 321. SU WY, DAY BJ, KANG BH, CRAPO JD, HUANG YC, CHANG LY: Lung epithelial cell-released nitric oxide protects against PMN-mediated cell injury. Am J Physiol 271:L581-L586, 1996
322. 322. RADOMSKI MW, PALMER RM, MONCADA S: Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br J Pharmacol 92:181-187, 1987
323. 323. RADOMSKI MW, PALMER RM, MONCADA S: Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2:1057-1058, 1987
324. 324. SHULTZ PJ, RAIJ L: Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 90:1718-1725, 1992
325. 325. WESTBERG G, SHULTZ PJ, RAIJ L: Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rats. Kidney Int 46:711-716, 1994
326. 326. MUHL H, SANDAU K, BRUNE B, BRINER VA, PFEILSCHIFTER J: Nitric oxide donors induce apoptosis in glomerular mesangial cells, epithelial cells and endothelial cells. Eur J Pharmacol 317:137-149, 1996
327. 327. GARG UC, HASSID A: Inhibition of rat mesangial cell mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 257:F60-F66, 1989
328. 328. CRAVEN PA, STUDER RK, FELDER J, PHILLIPS S, DERUBERTIS FR: Nitric oxide inhibition of transforming growth factor-β and collagen synthesis in mesangial cells. Diabetes 46:671-681, 1997
329. 329. IKEDA M, IKEDA U, TAKAHASHI M, SHIMADA K, MINOTA S, KANO S: Nitric oxide inhibits intracellular adhesion molecule-1 expression in rat mesangial cells. J Am Soc Nephrol 7:2213-2218, 1996
330. 330. ARMSTEAD VE, MINCHENKO AG, SCHUHL RA, HAYWARD R, NOSSULI TO, LEFER AM: Regulation of P-selectin expression in human endothelial cells by nitric oxide. Am J Physiol 273:H740-H746, 1997
331. 331. HABERSTROH U, STILO K, POCOCK J, WOLF G, HELMCHEN U, WENZEL U, ZAHNER G, STAHL RAK, THAISS F: L-Arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli. J Am Soc Nephrol 9:203-210, 1998
332. 332. WELCH WJ: Mammalian stress response: Cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol Rev 72:1063-1081, 1992
333. 333. YOKOO T, KITAMURA M: Heat shock protein in the kidney. Exp Nephrol 5:439-444, 1997
334. 334. HARTL FU: Molecular chaperones in cellular protein folding. Nature 381:571-579, 1996
335. 335. CRAIG EA, WEISSMAN JS, HORWICH AL: Heat shock proteins and molecular chaperones: Mediators of protein conformation and turnover in the cells. Cell 78:365-372, 1994
336. 336. KOMATSUDA A, WAKUI H, IMAI H, NAKAMOTO Y, MIURA AB, ITOH H, TASHIMA Y: Renal localization of the constitutive 73-kDa heat-shock protein in normal and PAN rats. Kidney Int 41:1204-1212, 1992
337. 337. YOKOO T, KITAMURA M: IL-1β depressed expression of the 70-kilodalton heat shock protein and sensitizes glomerular cells to oxidant-initiated apoptosis. J Immunol 159:2886-2892, 1997
338. 338. GABAI VL, MERIIN AB, MOSSER DD, CARON AW, RITS S, SHIFRIN VI, SHERMAN MY: Hsp70 prevents activation of stress kinases: A novel pathway of cellular thermotolerance. J Biol Chem 272: 18033-18037, 1997
339. 339. ISHIKAWA Y, YOKOO T, KITAMURA M: c-Jun/AP-1, but not NF-κB, is a mediator for oxidant-initiated apoptosis in glomerular mesangial cells. Biochem Biophys Res Commun 240:496-501, 1997
340. 340. WAKUI H, ITOH H, TASHIMA Y, KOBAYASHI R, NAKAMOTO Y, MIURA AB: Purification of a mature form of 60 kDa heat-shock protein (chaperonin homolog) from porcine kidney and its partial amino acid sequence. Int J Biochem 24:1507-1510, 1992
341. 341. MATSUBARA O, KASUGA T, MARUMO F, ITOH H, TASHIMA Y: Localization of 90-kDa heat shock protein in the kidney. Kidney Int 38:830-834, 1990
342. 342. MOLITERNO R, WOAN M, BENTLEJEWSKI C: Heat shock protein-induced T lymphocyte propagation from endomyocardial biopsies in heart transplantation. J Heart Lung Transplant 14:329-337, 1995
343. 343. GALEA-LAURI J, RICHARDSON AJ, LATCHMAN DS, KATZ DR: Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-α and cycloheximide: A possible role in immunology. J Immunol 157:4109-4118, 1996
344. 344. KAHN W, MCGUIRT JP, SENS MA, SENS DA, TODD JH: Expression of heat shock protein 27 in developing and adult human kidney. Toxicol Lett 84:69-79, 1996
345. 345. SMOYER WE, GUPTA A, MUNDEL P, BALLEW JD, WELSH MJ: Altered expression of glomerular heat shock protein 27 in experimental nephrotic syndrome. J Clin Invest 97:2697-2704, 1996
346. 346. MAINES MD: The heme oxygenase system: A regulator of second messenger gases. Annu Rev Pharmacol Toxicol 37:517-554, 1997
347. 347. APPLEGATE LA, LUSCHER P, TYRRELL RM: Induction of heme oxygenase: A general response to oxidant stress in cultured mammalian cells. Cancer Res 51:974-978, 1991
348. 348. STOCKER R: Induction of haem oxygenase as a defense against oxidative stress. Free Radic Res Commun 9:101-112, 1990
349. 349. LEE PJ, ALAM J, WIEGAND GW, CHOI AM: Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Nad Acad Sci USA 93:10393-10398, 1996
350. 350. WILLIS D, MOORE AR, FREDERICK R, WILLOUGHBY DA: Heme oxygenase: A novel target for the modulation of the inflammatory response. Nat Med 2:87-90, 1996
351. 351. LANIADO-SCHWARTZMAN M, ABRAHAM NG, CONNERS M, DUNN MW, LEVERE RD, KAPPAS A: Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol 53:1069-1075, 1997
352. 352. TETSUKA T, DAPHNA-IKEN D, SRIVASTAVA SK, MORRISON AR: Regulation of heme oxygenase mRNA in mesangial cells: Prostaglandin E2 negatively modulates interleukin-1-induced heme oxygenase-1 mRNA. Biochem Biophys Res Commun 212:617-623, 1995
353. 353. SCHENA FP, GESUALDO L, GRANDALIANO G, MONTINARO V: Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int 52:1439-1457, 1997
354. 354. YOSHIOKA T, ICHIKAWA I, FOGO A: Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2:902-912, 1991
355. 355. NAKAMURA H, NAKAMURA K, YODOI J: Redox regulation of cellular activation. Annu Rev Immunol 15:351-369, 1997
356. 356. SUZUKI YJ, FORMAN HJ, SEVANIAN A: Oxidants as stimulators of signal transduction. Free Radic Biol Med 22:269-285, 1997
357. 357. MAYER TN, GLOY J, HUG MJ, GREGER R, SCHOLLMEYER P, PAVENSTADT H: Hydrogen peroxide increases the intracellular calcium activity in rat mesangial cells in primary culture. Kidney Int 49:388-395, 1996
358. 358. YOKOO T, KITAMURA M: Unexpected protection of glomerular mesangial cells from oxidant-triggered apoptosis by bioflavonoid quercetin. Am J Physiol 273:F206-F212, 1997
359. 359. ANGEL P, KARIN M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129-157, 1991
360. 360. BAEUERLE PA, HENKEL T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 12:147-179, 1994
361. 361. SATRIANO JA, SHULDINER M, HORA K, XING Y, SHAN Z, SCHLÖNDORFF D: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G: Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92:1564-1571, 1993
362. 362. LO SK, JANAKIDEVI K, LAI L, MALIK AB: Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol 264:L406-L412, 1993
363. 363. ICHIKAWA I, KIYAMA S, YOSHIOKA T: Renal antioxidant enzymes: Their regulation and function. Kidney Int 45:1-9, 1994
364. 364. BANNISTER JV, BANNISTER WH, ROTILIO G: Aspects of the structure, function, and applications of Superoxide dismutase. CRC Crit Rev Biochem 22:111-180, 1987
365. 365. PRZEDBORSKI S, KOSTIC V, JACKSON-LEWIS V, NAINI AB, SIMONETTI S, FAHN S, CARLSON E, EPSTEIN CJ, CADET JL: Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 12:1658-1667, 1992
366. 366. WISPE JR, WARNER BB, CLARK JC, DEY CR, NEUMAN J, GLASSER SW, CRAPO JD, CHANG L-Y, WHITSETT JA: Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic mice confers protection from oxygen injury. J Biol Chem 267:23937-23941, 1992
367. 367. YOSHIOKA T, BILLS T, MOORE-JARRETT T, GREENE HL, BURR IM, ICHIKAWA I: Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int 38:282-288, 1990
368. 368. YOSHIOKA T, KAWAMURA T, MEYRICK BO, BECKMAN JK, HOOVER RL, YOSHIDA H, ICHIKAWA I: Induction of manganese Superoxide dismutase by glucocorticoids in glomerular cells. Kidney Int 45:211-219, 1994
369. 369. GWINNER W, TISHER CC, NICK HS: Regulation of manganese Superoxide dismutase in glomerular epithelial cells: Mechanisms for interleukin-1 induction. Kidney Int 48:354-362, 1995
370. 370. DIAMOND JR, BONVENTRE JV, KARNOVSKY MJ: A role for oxygen free radicals in aminonucleoside nephrosis. Kidney Int 29:478-483, 1986
371. 371. BEAMAN M, BIRTWISTLE R, HOWIE AJ, MICHAEL J, ADU D: The role of Superoxide anion and hydrogen peroxide in glomerular injury induced by puromycin aminonucleoside in rats. Clin Sci 73:329-332, 1987
372. 372. YOSHIOKA T, HOMMA T, MEYRICK B, TAKEDA M, MOORE-JARRETT T, KON V, ICHIKAWA I: Oxidants induce transcriptional activation of manganese Superoxide dismutase in glomerular cells. Kidney Int 46:405-413, 1994
373. 373. STEPHANZ GB, GWINNER W, CANNON JK, TISHER CC, NICK HS: Heat-aggregated IgG and interleukin-1β stimulate manganese superoxide dismutase in mesangial cells. Exp Nephrol 4:151-158, 1996
374. 374. ADACHI T, FUKUTA M, ITO Y, HIRANO K, SUGIURA M, SUGIURA K: Effect of Superoxide dismutase on glomerular nephritis. Biochem Pharmacol 35:341-345, 1986
375. 375. LINDAU-SHEPARD BA, SHAFFER JB: Expression of human catalase in acatalasemic murine SV-B2 cells confers protection from oxidative damage. Free Radic Biol Med 15:581-588, 1993
376. 376. LIEBMANN J, FISHER J, LIPSCHULTZ C, KUNO R, KAUFMAN DC: Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin. Cancer Res 55:4465-4470, 1995
377. 377. BALIGA R, BALIGA M, SHAH SV: Effect of selenium deficient diet in experimental glomerular disease. Am J Physiol 263:F56-F61, 1992
378. 378. NATH KA, SALAHUDEEN AK: Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 86:1179-1192, 1990
379. 379. HUNTER T: Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling. Cell 80:225-236, 1995
380. 380. WHITMARSH AJ, DAVIS RJ: Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J Mol Med 74:589-607, 1996
381. 381. BOKEMEYER D, SOROKIN A, DUNN MJ: Differential regulation of the dual-specificity protein-tyrosine phosphatases CL100, B23, and PAC1 in mesangial cells. J Am Soc Nephrol 8:40-50, 1997
382. 382. WENZEL UO, FOUQUERAY B, BISWAS P, GRANDALIANO G, CHOUDHURY GG, ABBOUD HE: Activation of mesangial cells by the phosphatase inhibitor vanadate: Potential implications for diabetic nephropathy. J Clin Invest 95:1244-1252, 1995
383. 383. FENG L, XIA Y, SEIFFERT D, WILSON CB: Oxidative stress-inducible protein tyrosine phosphatase in glomerulonephritis. Kidney Int 48:1920-1928, 1995
384. 384. CHENG J, WU K, ARMANINI M, O'ROURKE N, DOWBENKO D, LASKY LA: A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors. J Biol Chem 272:7264-7277, 1997
385. 385. TAGAWA M, SHIRASAWA T, YAHAGI Y, TOMODA T, KUROYANAGI H, FUJIMURA S, SAKIYAMA S, MARUYAMA N: Identification of a receptor-type protein-tyrosine phosphatase expressed in postmitotic maturing neurons: Its structure and expression in the central nervous system. Biochem J 321:865-871, 1997
386. 386. THOMAS PE, WHARRAM BL, GOYAL M, WIGGINS JE, HOLZMAN LB, WIGGINS RC: GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase: Identification, molecular cloning, and characterization in rabbit. J Biol Chem 269:19953-19962, 1994
387. 387. SHANKLAND SJ: Cell-cycle control and renal disease. Kidney Int 52:294-308, 1997
388. 388. SHEER CJ, ROBERTS JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995
389. Kip1. Kidney Int 51:1088-1099, 1997
390. 390. SHANKLAND SJ, HUGO C, COATS SR, NANGAKU M, PICHLER RH, GORDON KL, PIPPIN J, ROBERTS JM, COUSER WG, JOHNSON RJ: Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239, 1996
391. Kip1 safeguards against inflammatory injury. Nat Med 4:575-580, 1998
392. 392. SHANKLAND SJ, FLOEGE J, THOMAS SE, NANGAKU M, HUGO C, PIPPIN J, HENNE K, HOCKENBERRY DM, JOHNSON RJ, COUSER WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-413, 1997
393. 393. KAWAMURA T, YOSHIOKA T, BILLS T, FOGO A, ICHIKAWA I: Glucocorticoid activates glomerular antioxidant enzymes and protects glomeruli from oxidant injuries. Kidney Int 40:291-301, 1991
394. 394. KITAMURA M: Strategic gene transfer into the kidney: Current status and prospects. Clin Exp Nephrol 1:157-178, 1997
395. 395. KITAMURA M, FINE LG: Gene transfer into the kidney: Promises and limitations. Kidney Int 52:S86-S90, 1997
396. 396. TOMITA N, HIGAKI J, MORISHITA R, KATO K, MIKAMI H, KANEDA Y, OGIHARA T: Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 186:129-134, 1992
397. 397. IMAI E, ISAKA Y, AKAGI Y, KANEDA Y: Gene transfer into the glomerulus by hemagglutinating virus of Japan (HVJ)-liposome method, in Genetic Manipulation of the Kidney, edited by KITAMURA M. Exp Nephrol 5:112-117, 1997
398. 398. HEIKKILA P, PARPALA T, LUKKARINEN O, WEBER M, TRYGGVASON K: Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system: First step towards gene therapy of Alport syndrome. Gene Ther 3:21-27, 1996
399. 399. TRYGGVASON K, HEIKKILA P, PETTERSSON E, TIBELL A, THORNER P: Can Alport syndrome be treated by gene therapy? Kidney Int 51:1493-1499, 1997
400. 400. YOKOO T, KITAMURA M: Gene transfer of interleukin-1 receptor antagonist into the renal glomerulus via a mesangial cell vector. Biochem Biophys Res Commun 226:883-888, 1996
401. 401. KITAMURA M: Creation of a reversible on/off system for site-specific in vivo control of exogenous gene activity in the renal glomerulus. Proc Natl Acad Sci USA 93:7387-7391, 1996
402. 402. KITAMURA M, KAWACHI H: Creation of an in vivo cytosensor using engineered mesangial cells: Automatic sensing of glomerular inflammation controls transgene activity. J Clin Invest 100:1394-1399, 1997
403. 403. KOOYMAN DL, BYRNE GW, MCCLELLAN S, NIELSEN D, TONE M, WALDMANN H, COFFMAN TM, MCCURRY KR, PLATT JL, LOGAN JS: In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science 269:89-92, 1995
404. 404. MCCURRY KR, KOOYMAN DL, ALVARADO CG, COTTERELL AH, MARTIN MJ, LOGAN JS, PLATT JL: Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nat Med 1:423-427, 1995
405. 405. ZHU G, NICOLSON AG, ZHENG XX, STROM TB, SUKHATME VP: Adenovirus-mediated β-galactosidase gene delivery to the liver leads to protein deposition in kidney glomeruli. Kidney Int 52:992-999, 1997
406. 406. KAWACHI H, IWANAGA T, TOYABE S, OITE T, SHIMIZU F: Mesangial sclerotic change with persistent proteinuria in rats after two consecutive injection of monoclonal antibody 1-22-3. Clin Exp Immunol 90:129-134, 1992
407. 407. KASINATH BS: Glomerular endothelial cell proteoglycans: Regulation by TGF-β1. Arch Biochem Biophys 305:370-377, 1993
408. 408. FLOEGE J, JOHNSON RJ, GORDON K, IIDA H, PRITZL P, YOSHIMURA A, CAMPBELL C, ALPERS CE, COUSER WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
409. 409. MORIYAMA T, XIA C, MIYAI A, AKAGI Y, ISAKA Y, KANEKO T, KAWADA N, UEDA N, YAMAUCHI A, HORIO M, ANDO A, IMAI E, HORI M: Involvement of MAP kinase phosphatase-1 in mesangial cell growth regulation. Nephrology 3:443-453, 1997
410. 410. SUN H, CHARLES CH, LAU LF, TONKS NK: MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75:487-493, 1993
411. 411. FRANKLIN CC, KRAFT AS: Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells. J Biol Chem 272:16917-16923, 1997
412. 412. ANDERSON S, BRENNER BM: Intraglomerular hypertension: Implications and drug treatment. Annu Rev Med 39:243-253, 1988
413. 413. HARRIS RC, KONDO S, YASUDA T: Mechanical stress-cell function relationships in renal cells. Exp Nephrol 5:263-270, 1997